Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon Feb 11, 2021 6:35pm
359 Views
Post# 32547786

RE:RE:RE:Viemed News Release:

RE:RE:RE:Viemed News Release:

My notes from the Feb 22, 2018 webinar: 

Growth to date has been patient by patient. Have yet to score a shared savings program with a large patient load (e.g. 500) Have had conversations with the top 5 payors to develop these programs.

 



lscfa wrote:

Total guess. Commonwealth has 132 primary care providers. There are 209,000 in the USA. So Commonwealth could be treating 132/209,000 of the 1,250,000 copd stage 4 patients that Viemed says is its target market. => 789 patients x $12,000/yr = $9.5 million US annual revenue to VMD.  


 

ol_griz wrote: Nice.  Interesting arrangement.  Wonder if there will be more like this?

Website says 26 offices in the Phoenix area and over 100 providers.  What would that translate into in terms of patient numbers accessed by VMD?

 

 



<< Previous
Bullboard Posts
Next >>